XI Jornada Mineira de Reumatologia
1º Dia - 8/1/19
2º Dia - 8/2/19
3º Dia - 8/3/19

Remissão livre de drogas Voltar

Mariana Peixoto Guimarães U. E Silva de Souza

Mesa Redonda: Artrite Reumatoide - Presidente: Nelma Marchetti Mesquita; Moderador: Ana Maria S. Thiago Santiago Bez

Artigo Autor(es) Referência
An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients. Ito Satoshi, Kobayashi Daisuke, Hasegawa Eriko, Takai Chinatsu, Nemoto Tetsuya, Lee Hyunho, Abe Asami, Otani Hiroshi, Ishikawa Hajime, Murasawa Akira, Narita Ichiei, Nakazono Kiyoshi Internal medicine (Tokyo, Japan). 2019 Feb; 58(Feb):511-519. doi: 10.2169/internalmedicine.1332-18. pii: .
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology. Teitsma Xavier M, Yang Wei, Jacobs Johannes W G, Pethö-Schramm Attila, Borm Michelle E A, Harms Amy C, Hankemeier Thomas, van Laar Jacob M, Bijlsma Johannes W J, Lafeber Floris P J G Arthritis research & therapy. 2018 10; 20(10):230. doi: 10.1186/s13075-018-1729-2. pii: .
Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission? Liu Di, Yuan Na, Yu Guimei, Song Ge, Chen Yan American journal of translational research. 2017 ; 9():3758-3775.
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Bykerk Vivian P, Burmester Gerd R, Combe Bernard G, Furst Daniel E, Huizinga Tom W J, Ahmad Harris A, Emery Paul Rheumatology international. 2019 05; 39(05):945. doi: 10.1007/s00296-018-4232-9. pii: .
Drug-free remission: the goal of the future in management of patients with rheumatoid arthritis. Filipowicz-Sosnowska Anna Reumatologia. 55():284-289. doi: 10.5114/reum.2017.72625. pii: .
Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics. Teitsma Xavier M, Jacobs Johannes W G, Concepcion Arno N, Pethö-Schramm Attila, Borm Michelle E A, van Laar Jacob M, Bijlsma Johannes W J, Lafeber Floris P J G Clinical and experimental rheumatology. 36():976-983.
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study. Hashimoto Motomu, Furu Moritoshi, Yamamoto Wararu, Fujimura Takanori, Hara Ryota, Katayama Masaki, Ohnishi Akira, Akashi Kengo, Yoshida Shuzo, Nagai Koji, Son Yonsu, Amuro Hideki, Hirano Toru, Ebina Kosuke, Uozumi Ryuji, Ito Hiromu, Tanaka Masao, Ohmura Koichiro, Fujii Takao, Mimori Tsuneyo Arthritis research & therapy. 2018 08; 20(08):165. doi: 10.1186/s13075-018-1673-1. pii: .
In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remission. de Moel Emma C, Derksen Veerle F A M, Trouw Leendert A, Bang Holger, Goekoop-Ruiterman Yvonne P M, Steup-Beekman Gerda M, Huizinga Tom W J, Allaart Cornelia F, Toes René E M, van der Woude Diane Annals of the rheumatic diseases. 2018 12; 77(12):1836-1838. doi: 10.1136/annrheumdis-2018-213823. pii: .
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Bykerk Vivian P, Burmester Gerd R, Combe Bernard G, Furst Daniel E, Huizinga Tom W J, Ahmad Harris A, Emery Paul Rheumatology international. 2018 12; 38(12):2225-2231. doi: 10.1007/s00296-018-4173-3. pii: .
Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study. Baker Kenneth F, Skelton Andrew J, Lendrem Dennis W, Scadeng Adam, Thompson Ben, Pratt Arthur G, Isaacs John D Journal of autoimmunity. 2019 12; 105(12):102298. doi: 10.1016/j.jaut.2019.06.009. pii: S0896-8411(19)30196-9.
Rheumatoid arthritis: Moving towards IMPROVED drug-free remission. Bykerk Vivian P Nature reviews. Rheumatology. 2018 03; 14(03):191-192. doi: 10.1038/nrrheum.2018.49. pii: .
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now? Nagy György, van Vollenhoven Ronald F Arthritis research & therapy. 2015 Aug; 17(Aug):181. doi: 10.1186/s13075-015-0707-1. pii: .
Nenhuma revista foi definida para este congresso.